Company Avricore Health Inc.

AVCR

CA0545211090

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 12:28:14 2024-04-24 pm EDT			5-day change	1st Jan Change
0.14 ^CAD	-6.67%		0.00%	-17.65%

Apr. 04	Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations	MT
2023	Avricore Health Provides Update on Q3	MT

Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.

CAD in Million	2021	Weight	2022	Weight	Delta
Health Data and Point-of-care Technologies 100.0 %	0	100.0 %	2	100.0 %	+1,339.95%

CAD in Million	2021	Weight	2022	Weight	Delta
Canada 100.0 %	0	100.0 %	2	100.0 %	+1,339.95%

Managers	Title	Age	Since
Hector Bremner CEO	Chief Executive Officer	-	18-12-31
Kiki Smith DFI	Director of Finance/CFO	-	19-08-05
Rodger Seccombe CTO	Chief Tech/Sci/R&D Officer	-	20-12-07
Mark Kunzli PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
David Hall CHM	Chairman	71	16-01-19
Robert Sindelar BRD	Director/Board Member	71	18-03-26
Christine Hrudka BRD	Director/Board Member	-	23-06-20
Rodger Seccombe CTO	Chief Tech/Sci/R&D Officer	-	20-12-07
Alan Arnstein BRD	Director/Board Member	56	17-04-19
Hector Bremner CEO	Chief Executive Officer	-	18-12-31
Thomas Teahen BRD	Director/Board Member	-	23-06-20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	99,869,664	90,194,935 ( 90.31 %)	0	90.31 %

Name	Equities	%	Valuation
Rodger Seccombe 4.477 %	4,461,111	4.477 %	490 722 $
Hector Bremner 1.495 %	1,490,000	1.495 %	163 900 $
David Hall 1.372 %	1,367,618	1.372 %	150 438 $
Kiki Smith 0.9193 %	916,000	0.9193 %	100 760 $
Robert Sindelar 0.7978 %	795,000	0.7978 %	87 450 $
David Farnfield 0.6222 %	620,000	0.6222 %	68 200 $
Alan Arnstein 0.0251 %	25,000	0.0251 %	2 750 $
Christine Hrudka 0.0226 %	22,500	0.0226 %	2 475 $
Thomas Teahen 0.000000 %	0	0.000000 %	- $

Avricore Health, Inc.

789 West Pender Street Suite 1120

V6C 1H2, Vancouver

http://www.avricorehealth.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
AVRICORE HEALTH INC.	-17.65%	10.19M
ELI LILLY AND COMPANY	+25.61%	660B
NOVO NORDISK A/S	+23.78%	562B
JOHNSON & JOHNSON	-5.24%	358B
MERCK & CO., INC.	+16.49%	322B
ABBVIE INC.	+8.28%	297B
ASTRAZENECA PLC	+12.77%	219B
ROCHE HOLDING AG	-9.73%	196B
NOVARTIS AG	+6.89%	199B
PFIZER, INC.	-8.75%	149B

Other Pharmaceuticals